MEK-dependent ERK1/2 signaling inactivation clearly not only reduced SSRBC adhesion and vascular blockade but also decreased SSRBC trapping in organs typically affected in SCD, including the spleen, liver and lungs. This evidence concerns the gene MAP2K7 and Schnyder corneal dystrophy.